University of Cambridge and 52 North Health Limited KTP 21-22 R4
Lead Participant:
THE CHANCELLOR, MASTERS, AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Abstract
To synthesise new antibodies and develop new cutting-edge lateral flow-based diagnostics to support more precise monitoring of cancer patients at risk of complications from chemotherapy.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| THE CHANCELLOR, MASTERS, AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE | £202,532 | £ 135,696 |
Participant |
||
| INNOVATE UK | ||
| KTN LTD | ||
| NEUTROCHECK LTD | ||
| UNIVERSITY OF CAMBRIDGE |
People |
ORCID iD |